Sign in to view content

Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial

Peter A. Campochiaro, MD

Video
Published 2021

Related

Episode 11: Endophthalmitis after Intravitreal Anti-VEGF Injections with Dr. David Almeida
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Anti-VEGF Injection Prior Authorization Impacts on Retina Practices
Sabin Dang, MD
Updates from the Field
2022
Previous Intravitreal Therapy is Associated With Increased Risk of Posterior Capsule Rupture During Cataract Surgery
Aaron Y Lee, MD, MSCI
Updates from the Field
2016

Category: Pharmacology

See more